Effects of Pelargonium sidoides extract on chemokine levels in nasal secretions of patients with non-purulent acute rhinosinusitis-Reference-Cited by-同舟云学术

Effects of Pelargonium sidoides extract on chemokine levels in nasal secretions of patients with non-purulent acute rhinosinusitis

Published:2020-01-01 Issue:1 Volume:9 Page:145-150
ISSN:2155-6660
Container-title:Journal of Drug Assessment
language:en
Short-container-title:Journal of Drug Assessment

Author:

Perić Aleksandar¹²^ORCID,Vezmar Kovačević Sandra³,Barać Aleksandra⁴,Gaćeša Dejan⁵,Perić Aneta V.⁶,Vojvodić Danilo⁷

Affiliation:

1. Department of Otorhinolaryngology, Military Medical Academy Faculty of Medicine, University of Defense, Belgrade, Serbia

2. Medigroup General Hospital, Belgrade, Serbia

3. Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University in Belgrade, Belgrade, Serbia

4. Clinical Center of Serbia, School of Medicine, University in Belgrade, Belgrade, Serbia

5. ENT Hospital “Dr. Zutic”, Belgrade, Serbia

6. Institute for Pharmacy, Military Medical Academy Faculty of Medicine, University of Defense, Belgrade, Serbia

7. Institute for Medical Research, Division of Clinical and Experimental Immunology, Military Medical Academy Faculty of Medicine, University of Defense, Belgrade, Serbia

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21556660.2020.1838176

Reference23 articles.

1. Current healthcare pathways in the treatment of rhinosinusitis in Germany

2. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

3. Intravenous olfactory test latency correlates with improvement in post-infectious olfactory dysfunction

4. EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data;Frontiers in Pharmacology;2024-02-23

2. Acute and chronic rhinosinusitis age characteristics;Vestnik otorinolaringologii;2024

3. Mechanistic Evidence of Andrographis paniculata (Burm. f.) Wall. ex Nees, Pelargonium sidoides DC., Echinacea Species and a Combination of Hedera helix L., Primula veris L./Primula elatior L. and Thymus vulgaris L./Thymus zygis L. in the Treatment of Acute, Uncomplicated Respiratory Tract Infections: A Systematic Literature Review and Expert Interviews;Pharmaceuticals;2023-08-24

4. EPs® 7630 Stimulates Tissue Repair Mechanisms and Modifies Tight Junction Protein Expression in Human Airway Epithelial Cells;International Journal of Molecular Sciences;2023-07-07

5. Chronobiological Efficacy of Combined Therapy of Pelargonium Sidoides and Melatonin in Acute and Persistent Cases of COVID-19: A Hypothetical Approach;Advances in Experimental Medicine and Biology;2023